David Harvey, MD
MOHS-Micrographic Surgery · Newnan, GANPI 1578526232
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Misonix Inc at 39.7% of the total. Among mohs-micrographic surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $94.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Misonix Inc$7K
- Regeneron Healthcare Solutions, Inc.$5K
- Merz North America, Inc.$1K
- Sanofi$708
- AbbVie$395
- Amgen$245
- plus $2K from 32 others
What the payments were for
- Consulting fees$5,16230%
- Speaking & faculty fees$6,71640%
- Food & beverage$5,02030%
- Education$1011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSkin$6,600
- LIBTAYO$5,162
- XEOMIN$796
- Kerecis Omega3 Marigen$438
- Kerecis Omega3 SurgiClose$146
- Kerecis Omega3 GraftGuide$146
- AMELUZ$129
- BF-RhodoLED$129
- XEPI$129
How this compares
$16,999 in reported general payments places this provider in the 90th percentile of 40 mohs-micrographic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 16 | $77,658 |
| Mupirocin | 441 | $3,329 |
| Doxycycline Hyclate | 111 | $1,004 |
| Gentamicin Sulfate | 31 | $955 |
| Cefadroxil | 66 | $586 |
| Clobetasol Propionate | 25 | $546 |
| ErythromycinErythromycin Base | 30 | $383 |
| ValacyclovirValacyclovir Hcl | 15 | $379 |
| Triamcinolone Acetonide | 24 | $346 |
| Ketoconazole | 34 | $320 |
| Cephalexin | 28 | $228 |
| Fluconazole | 14 | $225 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $153 |
| Doxycycline Monohydrate | 11 | $120 |
| Levofloxacin | 15 | $73 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Newnan
- Steven MarcetNewnan$2K
- Wallace NozileStockbridge$213K
- Brandon BurrowayDuluth$30K
- John KayalMarietta$27K
- David OlanskyAtlanta$13K
- David KentMacon$11K
- Diamondis PapadopoulosAtlanta$9K
- Sidney SmithSavannah$9K
- Steven KentMacon$8K
- Danielle LazzaraMilton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.